Suppr超能文献

肝细胞癌肝切除术后90天死亡率的预测因素

Predictors of 90-Day Mortality following Hepatic Resection for Hepatocellular Carcinoma.

作者信息

Lei Geraldine Yanlei, Shen Liang, Junnarkar Sameer P, Huey CheongWei Terence, Low JeeKeem, Shelat Vishal G

机构信息

Department of General Surgery, Ministry of Health Holdings, Singapore, Singapore.

Department of Biostatistics Unit, National University Health System, Singapore, Singapore.

出版信息

Visc Med. 2021 Mar;37(2):102-109. doi: 10.1159/000510811. Epub 2020 Oct 27.

Abstract

BACKGROUND/PURPOSE: 90-day mortality is a key performance indicator for short-term perioperative outcome of hepatic resection (HR). Although many preoperative, intraoperative, and postoperative variables predict 90-day mortality following elective HR, only few are specific to hepatocellular carcinoma (HCC). This study aims to determine the predictors of 90-day mortality following elective HR for HCC.

METHODS

We report a retrospective analysis of patients who underwent elective HR between January 1, 2007, and December 31, 2017. Health status, perioperative variables, and the presence of post-hepatectomy liver failure (PHLF) were studied. Cox's regression evaluated factors predicting 90-day mortality.

RESULTS

Two hundred and forty-four patients diagnosed with HCC underwent HR; 102 (41.8%) underwent a major HR. The postoperative 90-day mortality rate was 5.3%. Multivariate analysis demonstrated that Child-Pugh score ( < 0.001), intraoperative blood loss ( = 0.013), the 50-50 criteria for PHLF ( < 0.001) on postoperative day 5, and peak serum bilirubin >119 µmol/L ( = 0.007) on postoperative day 3 predict 90-day mortality.

CONCLUSION

In patients with HCC undergoing HR, Child-Pugh score, intraoperative blood loss, the 50-50 criteria for PHLF on postoperative day 5, and peak serum bilirubin >119 µmol/L on postoperative day 3 predict 90-day mortality following elective HR for HCC.

摘要

背景/目的:90天死亡率是肝切除(HR)围手术期短期结局的关键性能指标。尽管许多术前、术中和术后变量可预测择期HR后的90天死亡率,但只有少数变量是肝细胞癌(HCC)特有的。本研究旨在确定HCC择期HR后90天死亡率的预测因素。

方法

我们报告了对2007年1月1日至2017年12月31日期间接受择期HR的患者的回顾性分析。研究了健康状况、围手术期变量以及肝切除术后肝衰竭(PHLF)的存在情况。Cox回归评估了预测90天死亡率的因素。

结果

244例诊断为HCC的患者接受了HR;102例(41.8%)接受了大肝切除。术后90天死亡率为5.3%。多变量分析表明,Child-Pugh评分(<0.001)、术中失血量(=0.013)、术后第5天的PHLF 50-50标准(<0.001)以及术后第3天血清胆红素峰值>119 µmol/L(=0.007)可预测90天死亡率。

结论

在接受HR的HCC患者中,Child-Pugh评分、术中失血量、术后第5天的PHLF 50-50标准以及术后第3天血清胆红素峰值>119 µmol/L可预测HCC择期HR后的90天死亡率。

相似文献

1
Predictors of 90-Day Mortality following Hepatic Resection for Hepatocellular Carcinoma.
Visc Med. 2021 Mar;37(2):102-109. doi: 10.1159/000510811. Epub 2020 Oct 27.
2
Predictors of mortality within the first year post-hepatectomy for hepatocellular carcinoma.
J Egypt Natl Canc Inst. 2022 Apr 4;34(1):14. doi: 10.1186/s43046-022-00113-8.
3
A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.
Clin Res Hepatol Gastroenterol. 2021 Jul;45(4):101534. doi: 10.1016/j.clinre.2020.09.001. Epub 2020 Oct 13.
5
A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.
Eur Radiol. 2022 Aug;32(8):5623-5632. doi: 10.1007/s00330-022-08656-z. Epub 2022 Mar 16.

引用本文的文献

1
Path towards personalized care of hepatocellular carcinoma: a nomogram for survival prediction.
J Gastrointest Oncol. 2025 Jun 30;16(3):1347-1350. doi: 10.21037/jgo-2025-298. Epub 2025 Jun 24.
2
Predictors for 30-day mortality in hepatocellular carcinoma patients undergoing liver resection.
Narra J. 2024 Dec;4(3):e1001. doi: 10.52225/narra.v4i3.1001. Epub 2024 Oct 11.

本文引用的文献

1
Associated liver partition and portal vein ligation for staged hepatectomy: a review.
Transl Gastroenterol Hepatol. 2020 Jul 5;5:37. doi: 10.21037/tgh.2019.12.01. eCollection 2020.
3
Comparison of score-based prediction of 90-day mortality after liver resection.
BMC Surg. 2020 Jan 29;20(1):19. doi: 10.1186/s12893-020-0678-2.
4
Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
Eur J Surg Oncol. 2020 May;46(5):763-771. doi: 10.1016/j.ejso.2020.01.004. Epub 2020 Jan 7.
5
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
J Hepatol. 2020 Jan;72(1):75-84. doi: 10.1016/j.jhep.2019.08.032. Epub 2019 Sep 6.
7
Red blood cell transfusion and its alternatives in oncologic surgery-A critical evaluation.
Crit Rev Oncol Hematol. 2019 Feb;134:1-9. doi: 10.1016/j.critrevonc.2018.11.011. Epub 2018 Dec 6.
8
Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma.
Ann Gastroenterol Surg. 2018 Sep 27;3(1):65-74. doi: 10.1002/ags3.12212. eCollection 2019 Jan.
9
Risk assessment for liver resection.
Surgery. 2018 Nov;164(5):998-1005. doi: 10.1016/j.surg.2018.06.024. Epub 2018 Aug 12.
10
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验